Esophageal Cancer Clinical Trials in Zhengzhou, Henan
13 recruitingZhengzhou, Henan, China
Showing 1–13 of 13 trials
Recruiting
Phase 1Phase 2
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
Esophageal CancerEsophageal NeoplasmsGastroesophageal Junction+1 more
Merck Sharp & Dohme LLC160 enrolled43 locationsNCT06469944
Recruiting
Phase 1Phase 2
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
Esophageal CancerEsophageal NeoplasmsGastroesophageal Junction+1 more
Merck Sharp & Dohme LLC210 enrolled43 locationsNCT06445972
Recruiting
Phase 1Phase 2
Clinical Trial Evaluating TQB6411 Injection in Subjects With Esophageal Cancer
Esophageal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.105 enrolled30 locationsNCT07367516
Recruiting
Phase 1
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Esophageal CancerProstate CancerLung Cancer (NSCLC)+1 more
Phrontline Biopharma200 enrolled7 locationsNCT07181473
Recruiting
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma
Esophageal Cancer
Xijing Hospital300 enrolled9 locationsNCT06979869
Recruiting
Phase 1
APG-2449 in Patients With Advanced Solid Tumors
Esophageal CancerOvarian CancerNon-small Cell Lung Cancer+2 more
Ascentage Pharma Group Inc.165 enrolled9 locationsNCT03917043
Recruiting
Phase 2
Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University112 enrolled1 locationNCT06718205
Recruiting
Phase 2
Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC
Esophageal Cancer by AJCC V8 Stage
The First Affiliated Hospital of Zhengzhou University188 enrolled1 locationNCT05738434
Recruiting
Phase 2
A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University147 enrolled1 locationNCT03736863
Recruiting
a Single-arm, Single-center, Open Clinical Study
Esophageal CancerGastric CancerNon-small Cell Lung Cancer (NSCLC)+2 more
Beijing Geekgene Technology Co., LTD10 enrolled1 locationNCT06431100
Recruiting
Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)
Esophageal Cancer
Fudan University385 enrolled11 locationsNCT05443841
Recruiting
Phase 3
Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
Esophageal CancerSurgeryNeoadjuvant Treatment+1 more
Henan Cancer Hospital400 enrolled1 locationNCT04280822
Recruiting
Phase 2
A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University130 enrolled1 locationNCT05182944